Conceivably, BARX1, together with CDC20, CDC45, TRIM37, MMP plus ZFP36 may have potential diagnosis and prognosis values in NSCLC, although these data were limited by the small sample size due to that we excluded patients who had received chemotherapy or radiotherapy. The gene discussed is BARX1; the disease is non-small cell lung carcinoma.